DexCom, Inc. (DXCM)
67.31
+0.98
(+1.48%)
USD |
NASDAQ |
Dec 10, 12:56
DexCom Profit Margin (Quarterly): 23.47% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 14.07% |
| BioLife Solutions, Inc. | 2.21% |
| Boston Scientific Corp. | 14.91% |
| Insulet Corp. | 12.40% |
| Eli Lilly & Co. | 31.72% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 30.94% |
| Return on Assets | 10.47% |
| Return on Invested Capital | 14.67% |
| Gross Profit Margin (Quarterly) | 61.80% |
| Operating Margin (Quarterly) | 20.05% |
| Return on Net Operating Assets | 21.55% |